BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33515064)

  • 1. Oncological outcomes in patients with pT1N0-3 or pT2-3N0 gastric cancer after curative resection without adjuvant chemotherapy.
    Yagi S; Nunobe S; Makuuchi R; Ida S; Kumagai K; Ohashi M; Sano T
    Langenbecks Arch Surg; 2021 Mar; 406(2):419-426. PubMed ID: 33515064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular invasion is associated with poor long-term outcomes in patients with pT1N0-3 or pT2-3N0 remnant gastric cancer: a retrospective cohort study.
    Sumiyoshi S; Ohashi T; Kubota T; Nishibeppu K; Owada K; Kiuchi J; Shimizu H; Arita T; Iitaka D; Yamamoto Y; Konishi H; Morimura R; Watanabe K; Kuriu Y; Shiozaki A; Ikoma H; Fujiwara H; Yamaoka N; Otsuji E
    World J Surg Oncol; 2024 Apr; 22(1):86. PubMed ID: 38581014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2-3N0 Gastric Cancer: a Multi-institutional Dataset Analysis.
    Fujita K; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    J Gastric Cancer; 2020 Mar; 20(1):41-49. PubMed ID: 32269843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the prognostic factors in patients with pT3N0 or pT1N2-3 gastric cancer: a single institutional retrospective cohort study.
    Terada M; Kinoshita T; Kaito A; Sugita S; Watanabe M; Hayashi R
    Surg Today; 2018 Mar; 48(3):325-332. PubMed ID: 28993997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 7. Is surgery alone sufficient for treating T1 gastric cancer with extensive lymph node metastases?
    Yura M; Yoshikawa T; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
    Gastric Cancer; 2020 Mar; 23(2):349-355. PubMed ID: 31512081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
    Shin HB; An JY; Lee SH; Choi YY; Kim JW; Sohn SS; Noh SH
    BMC Cancer; 2017 Apr; 17(1):287. PubMed ID: 28431518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
    Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
    Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of Examined Lymph Nodes as a Risk Factor for Recurrence in pT1N+ or pT2-3N0 Gastric Cancer.
    Nishimuta M; Arai J; Hamasaki K; Hashimoto Y; Nonaka T; Tominaga T; Oyama S; Yasutake T; Sawai T; Nagayasu T
    Cancer Diagn Progn; 2022; 2(5):558-563. PubMed ID: 36060028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study.
    Oh N; Kim H; Kim KM; Cheong JH; Lee J; Noh SH; Sohn TS; Choi YY; An JY
    Ann Surg Oncol; 2021 Dec; 28(13):8908-8915. PubMed ID: 34401986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
    Peng L; Yang W; Zhang Z; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
    Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China.
    Zhao J; Du F; Zhang Y; Kan J; Dong L; Shen G; Zheng F; Chen H; Zhao J; Ji F; Luo Y; Ma F; Wang Z; Xu B
    Medicine (Baltimore); 2016 Aug; 95(31):e4420. PubMed ID: 27495062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of spleen density in predicting prognosis of patients with gastric cancer after curative gastrectomy].
    Li S; Ma PF; Zhang JL; Cao YH; Liu CY; Zhang XJ; Li ZY; Xue YW; Zhao YZ
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2703-2709. PubMed ID: 34510877
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of visceral adipose tissue on compliance of adjuvant chemotherapy and relapse-free survival after gastrectomy for gastric cancer: A propensity score matching analysis.
    Matsui R; Inaki N; Tsuji T
    Clin Nutr; 2021 May; 40(5):2745-2753. PubMed ID: 33933740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is adjuvant chemotherapy necessary for early gastric cancer?
    Mei Y; Feng T; Yan M; Zhu Z; Zhu Z
    Cancer Biol Med; 2021 Jun; 19(4):518-32. PubMed ID: 34160167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Therapy is Associated with Improved Survival in pT1N1 Gastric Cancer in a Heterogeneous Western Patient Population.
    Hester CA; Augustine MM; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Wang SC; Porembka MR
    Ann Surg Oncol; 2019 Jan; 26(1):167-176. PubMed ID: 30421058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
    Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.